Previous Article | Next Article 
Journal of Virology, December 2001, p. 11773-11780, Vol. 75, No. 23
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.23.11773-11780.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Amino Acids Responsible for the Absolute Sialidase
Activity of the Influenza A Virus Neuraminidase: Relationship to
Growth in the Duck Intestine
Darwyn
Kobasa,1
Krisna
Wells,1 and
Yoshihiro
Kawaoka1,2,*
Department of Pathobiological Sciences,
School of Veterinary Medicine, University of Wisconsin
Madison,
Madison, Wisconsin 53706,1 and Institute
of Medical Science, University of Tokyo, Minato-ku, Tokyo 108-8639, Japan2
Received 13 April 2001/Accepted 21 August 2001
 |
ABSTRACT |
The 1957 human pandemic strain of influenza A virus contained an
avian virus hemagglutinin (HA) and neuraminidase (NA), both of which
acquired specificity for the human receptor,
N-acetylneuraminic acid linked to galactose of cellular
glycoconjugates via an
2-6 bond (NeuAc
2-6Gal). Although the NA
retained considerable specificity for NeuAc
2-3Gal, its original
substrate in ducks, it lost the ability to support viral growth in the
duck intestine, suggesting a growth-restrictive change other than a
shift in substrate specificity. To test this possibility, we generated
a panel of reassortant viruses that expressed the NA genes of
human H2N2 viruses isolated from 1957 to 1968 with all other genes from
the avian virus A/duck/Hong Kong/278/78 (H9N2). Only the NA of
A/Singapore/1/57 supported efficient viral growth in the intestines of
orally inoculated ducks. The growth-supporting capacity of the NA
correlated with a high level of enzymatic activity, comparable to that
found to be associated with avian virus NAs. The specific activities of the A/Ann Arbor/6/60 and A/England/12/62 NAs, which showed greatly restricted abilities to support viral growth in ducks, were only 8 and
5%, respectively, of the NA specific activity for A/Singapore/1/57. Using chimeric constructs based on A/Singapore/1/57 and A/England/12/62 NAs, we localized the determinants of high specific NA activity to a
region containing six amino acid substitutions in A/England/12/62: Ser331
Arg, Asp339
Asn, Asn367
Ser, Ser370
Leu, Asn400
Ser,
and Pro431
Glu. Five of these six residues (excluding Asn400) were required and sufficient for the full specific activity of the A/Singapore/1/57 NA. Thus, in addition to a change in substrate specificity, a reduction in high specific activity may be required for
the adaptation of avian virus NAs to growth in humans. This change is
likely needed to maintain an optimal balance between NA activity and
the lower affinity shown by human virus HAs for their cellular receptor.
 |
INTRODUCTION |
During replication, influenza A viruses require
the activities of two viral surface glycoproteins, hemagglutinin (HA),
responsible for binding to terminal sialic acid on cell surface
glycoconjugates, and neuraminidase (NA), with an associated enzymatic
activity that removes sialic acid from host cell glycoconjugates as
well as newly synthesized viral proteins to facilitate the budding of
progeny virions from cells (16). The primordial reservoir for all subtypes of influenza A viruses is believed to be wild aquatic
birds (26), and the activities of these two proteins in
avian viruses are highly adapted to the specific recognition of
N-acetylneuraminic acid (NeuAc) attached via an
2-3
linkage to neighboring galactose (
2-3Gal). NeuAc
2-3Gal is
important for the replication of influenza viruses in the intestines of aquatic birds, the natural site of virus replication in these hosts
(7, 8, 18, 19). In addition, the opposing activities of HA
and NA must be balanced (4, 6, 13, 14) to ensure that NA
possesses sufficient enzymatic activity to remove sialic acids from
infected cells but does not reduce the efficiency of infection by
removing sialic acid from uninfected cells before virus attachment occurs.
Occasionally viruses are transmitted to other host species, resulting
in severe outbreaks of disease and often the long-term establishment of
a new viral strain in the nonavian host (reviewed in reference
26). In the last century, at least two outbreaks, in 1957 and 1968, associated with transmission of avian viruses or the
introduction of avian viral genes into human viruses led to serious
pandemics. After the appearance of these viruses in humans, HA variants
were selected that had a higher specificity for the major species of
sialic acid, NeuAc-
2-6-galactose (NeuAc
2-6Gal), on cells of the
upper respiratory tract in humans than for the original receptor,
NeuAc
2-3Gal, in wild aquatic birds (2, 3, 18, 19). The
N2 subtype of NA first appeared in human viruses in the 1957 outbreak
of H2N2 virus and over several years gradually acquired an increased
substrate specificity for NeuAc
2-6Gal while maintaining significant
specificity for the original target of its activity in birds,
NeuAc
2-3Gal (1, 10).
However, even though the human virus N2 NA maintained substantial
specificity for NeuAc
2-3Gal, it became altered in its ability to
support viral growth in ducks. Orally inoculated avian viruses can
replicate to a high titer in the lower intestines of ducks. A
reassortant virus, containing the N2 NA gene of human virus A/Udorn/307/72 (H3N2) and all other genes from an avian virus, A/mallard/New York/6750/72, was not able to replicate in the lower intestines of orally inoculated ducks (5). This difference in growth of the parent avian virus versus the reassortant virus stemmed from differences between the avian and human NAs that occurred
as a consequence of adaptation of the NA to growth in humans.
Because the human virus NA has retained appreciable specificity for
NeuAc
2-3Gal despite acquiring specificity for NeuAc
2-6Gal, we
asked why it has lost the ability to support viral replication in
ducks. Apparently, NA substrate specificity, while an important determinant of the ability of an influenza virus to replicate in any
host, is not sufficient to explain the differences in host range
properties between avian and human viruses. To better understand the
role of NA in host range restriction, we generated a series of
reassortants in which the NA of an avian virus, A/duck/Hong Kong/278/78
(H2N9), was replaced with the N2 NAs from a series of human H2N2
viruses isolated between 1957 and 1968. The ability of each reassortant
to grow in ducks was assessed to determine when the human virus NA lost
the ability to support virus growth in these hosts. Differences in the
enzymatic activities of the NAs were also assessed to identify
differences in the NAs that might be related to the restriction of
growth in ducks.
 |
MATERIALS AND METHODS |
Viruses, cells, and antibodies.
Two avian influenza viruses,
A/duck/Hong Kong/278/78 (H2N9) and A/duck/Hong Kong/7/75 (H3N2), and
four H2N2 human viruses, A/Singapore/1/57, A/Ann Arbor/6/60,
A/England/12/62, and A/Korea/426/68, were obtained from the repository
at St. Jude Children's Research Hospital. Madin-Darby canine kidney
(MDCK) cells were cultured in Eagle's minimum essential medium with
5% newborn calf serum, and 293T cells were cultured in Dulbecco's
modified Eagle medium supplemented with 10% fetal calf serum. For
selection of reassortant viruses expressing N2 NAs, a pool of several
monoclonal antibodies specific for the N9 NA were used. This antibody
pool and a pool of anti-N2 monoclonal antibodies were used for
inhibition assays.
Generation of reassortant viruses.
Reassortant viruses were
generated with all genes except that for NA derived from avian virus
A/duck/Hong Kong/278/78 (H2N9) by using a previously described
procedure (24). The NA genes of the reassortants were
derived from the human H2N2 viruses A/Singapore/1/57, A/Ann Arbor/6/60,
A/England/12/62, and A/Korea/426/68, and the reassortants were
subsequently designated Dk78/Sing57N2, Dk78/AA60N2, Dk78/Eng62N2, and
Dk78/Korea68N2, respectively. After identifying the viruses that
expressed the N2 NA, we extracted viral RNAs from infection
supernatants by phenol-chloroform extraction and ethanol-sodium acetate
precipitation. cDNA was generated for each viral genome segment by
using UNI12, a primer complementary to the 12-base sequence at the 3'
end of the viral RNA that is identical among all the segments, and
Moloney murine leukemia virus reverse transcriptase (Promega, Madison,
Wis.). The genotypes of the internal gene segments were
determined by PCR with a primer pair that is specific for the avian
virus gene segment and another for the human virus gene segment for all
of the internal genes. In cases where PCR was not diagnostic (i.e.,
both primer pairs for a given gene yielded an amplification product),
the PCR products were further analyzed by restriction enzyme digestion
with enzymes specific for only one of the gene sequences. The identity
of the H2 HA incorporated into the reassortants was also determined by PCR amplification of a portion of the gene, followed by digestion with
restriction enzymes specific for the avian and human H2 HAs. The
sequences of all primers are available upon request. Only reassortants
expressing the N2 gene from the human viruses and all other genes from
the avian viruses were used for growth analysis in ducks. Each
reassortant was plaque purified three times on MDCK cells and then
inoculated into 11-day-old embryonated chicken eggs. Allantoic fluid
stocks were kept at
70°C.
Growth of reassortant viruses in ducks.
Pekin ducks
(Ridgeway Hatcheries, LaRue, Ohio) were orally inoculated with equal
titers (median egg infectious dose, 6.75) of each reassortant virus.
Three days postinfection, the ducks were sacrificed and a 6-cm-long
portion of the colon was removed. The tissue was homogenized and
resuspended in phosphate-buffered saline (PBS) containing antibiotics,
and the virus in the PBS suspension was titrated in 11-day-old
embryonated chicken eggs. Allantoic fluid harvested from each egg was
tested for virus by hemagglutination assay with chicken red blood cells.
NA enzymatic activity assays.
NA enzymatic activity was
determined by using
2'-(4-methylumbelliferyl)-
-D-N-acetylneuraminic
acid (MU-NANA) (Sigma), and sialyllactose containing NeuAc bound to the
galactose of lactose through an
2-3 ketosidic linkage
(NeuAc
2-3Gal) (Sigma), as previously described (10). NA
activities were determined with cell-expressed NAs and concentrated
virus preparations as previously described (10). In all
assays, a time course analysis with several dilutions of cell-expressed
NA or virus was performed to determine the optimal conditions for
comparison of NA activities. Assay conditions were selected to
determine NA activities within the linear range of the sialidase
activity-versus-time plot for all of the NAs. The data reported are the
means of duplicate reactions for each sample and are representative of
two or three separate assays.
Immunoprecipitation of NA.
Twenty microliters of virus was
diluted 1:10 in RIPA buffer (150 mM NaCl, 50 mM Tris-HCl [pH 7.4], 5 mM EDTA, 1% Triton X-100, 1% sodium deoxycholate, 1% sodium dodecyl
sulfate [SDS]) and incubated for 15 min at 37°C. One microliter of
the anti-N2 monoclonal antibody pool was added to the disrupted virus,
and the mixture was incubated at room temperature for 2 h. Next,
80 µl of a 50% suspension of protein A beads (RepliGen, Needham,
Mass.), previously washed three times in RIPA buffer, was added and
incubated at room temperature for 2 h with gentle agitation. The
beads were collected by centrifugation and washed three times with RIPA
buffer and then once with 50 mM Tris-HCl (pH 6.8) in a clean tube. The
beads were resuspended in SDS-polyacrylamide gel electrophoresis sample
buffer (nonreducing) in preparation for electrophoresis.
Determination of relative specific activities of NA in
reassortant virions.
One 175-cm2 flask of
MDCK cells at 90% confluency was infected with Dk78/Sing57N2,
Dk78/AA60N2, or Dk78/Eng62N2 at a multiplicity of infection of 1 and
maintained in minimum essential medium-bovine serum albumin. Similarly,
one flask of cells was infected with Dk78/75N2, a virus previously
generated by reverse genetics that contains the H2 HA gene and all
internal genes from A/duck/Hong Kong/278/78 and the N2 NA gene from
A/duck/Hong Kong/7/75 (9). This virus grows efficiently in
the duck intestine and provided an avian N2 NA for comparison with the
specific activities of the human N2 NAs. Four hours postinfection, the
medium was replaced with methionine- and cysteine-deficient RPMI 1640 (ICN, Costa Mesa, Calif.) supplemented with
N-tosyl-L-phenylalanine chloromethyl ketone-treated trypsin for 1 h to deplete the endogenous
reserves of methionine and cysteine. Then, 250 µCi of
methionine-cysteine Trans35S-Label (ICN) was
added to each flask. The supernatants were harvested at 24 h
postinfection, following lysis of 100% of the cells in each flask. The
supernatant fluids were centrifuged at 5,000 × g for
30 min in an SW28 rotor to pellet cell debris, and the virus was
pelleted by centrifugation at 65,000 × g for 1.5 h. Each pellet was resuspended in 200 µl of PBS, divided into
aliquots, and stored at
20°C.
The enzymatic activity of each concentrated virus was determined as
described above in equal volumes of virus preparation, thus providing a
comparison of NA activity per unit volume of virus stock. Next, the
viral proteins from an equal volume of each virus preparation were
separated by electrophoresis in an SDS-9% polyacrylamide gel under
nonreducing conditions. To identify NA bands on the gel,
immunoprecipitation of the NA from each of the virus preparations was
performed as described above and resolved on the same gel as the virus
preparations. The viral proteins were detected by autoradiography. Each
immunoprecipitated NA resolved as a high-molecular-weight double band
that corresponded to a double band in an identical position in each
whole-virus lane. The relative NA protein content in each virus
preparation was determined from the combined optical densities of both
NA bands, as previously described (9). The NA activity
(determined as described above) divided by the NA protein content
provided the relative specific activity of each NA, reported here as a
normalized value relative to that of Dk78/75N2.
Cloning of viral NA genes and generation of chimeric NA
constructs.
The full-length NA genes from Dk78/Sing57N2 and
Dk78/Eng62N2 were cloned into pUC19 and the plasmid expression vector
pCAGGS/MCS, as previously described (10, 15),
generating the constructs pUC/Sing57N2, pCA/Sing57N2, pUC/Eng62N2, and
pCA/Eng62N2. The sequences of these NAs were confirmed to be identical
to those of the original parent viruses, A/Singapore/1/57 and
A/England/12/62. To provide a common antibody recognition sequence for
protein quantitation of cell-expressed NA, we inserted the coding
sequence for the FLAG epitope tag (DYKDDDDK) (17) in frame
into the region of each NA gene coding for the stalk after Pro45.
Mutagenesis was performed with the oligonucleotide
5'-GCATTACTTGGTTGCTCGCCCTTGTCATCGTCGTCCTTGTAGT-3' and the
Clontech Transformer site-directed mutagenesis kit (number K1600-1),
according to the manufacturer's instructions. Sequence analysis
confirmed insertion of the FLAG sequence, whose presence did not affect
the enzymatic activities of the NAs (data not shown).
Five chimeric constructs of A/Singapore/1/57 and A/England/12/62 were
generated as described previously (10) (see Fig. 2A).
Site-specific mutagenesis of A/England/12/62 NA amino acid
residues.
To study the contributions of particular amino acid
residues to NA specific activity, we replaced certain residues of the A/England/12/62 NA with those of A/Singapore/1/57. Mutations were generated in the coding sequences of amino acid residues 331, 339, 367, 370, 400, and 431 individually and/or in groups of two or more.
Mutagenesis of individual residues at positions 367(Ser
Asn) and 370 (Leu
Ser) was performed with the oligonucleotides
5'-GCGCAAATCCTTGTTGATCGTTCTTCCC-3' and
5'-CCTGTTAACCTGAGCGTGAATCCTTGCTGATCG-3', respectively, and the Clontech Transformer site-directed mutagenesis kit, as described above.
Residue 400 (Ser
Asn) was mutated by amplification with the mutagenic
PCR primer 5'-GTCATAGTTGACAACAATAATTGGTCAGG-3', which contains the HindII site of the NA gene at nucleotide
position 1213, and the reverse primer
5'-ATGACCATGATTACGCCAAGCTTGC-3', which binds nucleotides 445 to 469 of the pUC19 MCS (10). The Glu431
Pro mutation in
pUC/Eng62N2 was introduced by PCR amplification of construct
pUC/Sing57N2 with a mutagenic primer,
5'-GTCATAGTTGACAGCAATAATTGGTCTGG-3', which binds in the same
position as the above mutagenic forward primer, and the reverse primer
listed above. Within this region there are only two nucleotide
differences that result in amino acid differences between the
A/England/12/62 and A/Singapore/1/57 NAs. Mutagenesis altered
A/Singapore/1/57 residue Asn400 to A/England/12/62 residue Ser400, and
when this fragment was subcloned into pUC/Eng62N2, the net effect was a
shift from Gln431 to Pro431. All mutants were confirmed by sequencing
and subcloned into pCAGGS/MCS.
Amino acids found in the A/Singapore/1/57 NA were introduced into the
A/England/12/62 NA in groups of two or more by subcloning appropriate
fragments from suitable constructs, using the shared NheI,
EcoRV, FokI, and HindII
restriction enzyme sites at positions 626, 869, 1105, and 1213, respectively, and Asp718 in the pUC19 MCS.
Determination of relative specific activities of expressed
NAs.
The pCAGGS/MCS expression plasmid for each wild-type,
chimeric, or mutant NA was expressed in 293T cells (two
10-cm2 wells per construct) as previously
described (10). NA enzymatic activity was determined with
the NeuAc
2-3Gal sialyllactose and MU-NANA substrates, as described
above, in dilutions of equal volumes of each cell suspension. After
determination of the cell surface-expressed NA activity, the cell
membranes were isolated for quantitation of the membrane-associated NA
protein. Cells were pelleted by centrifugation at 500 × g for 30 s, resuspended in 1 ml of ice-cold Dounce
buffer (10 mM Tris-Cl [pH 7.5] and 0.5 mM
MgCl2, with the protease inhibitors leupeptin
[10 µg/ml], aprotinin [10 µg/ml], phenylmethylsulfonyl fluoride
[1 mM], and iodoacetamide [1.8 mg/ml]), and incubated on ice for 10 min. The cells were lysed by 30 strokes in a Dounce homogenizer with
the tight (type B) pestle, and tonicity restoration buffer (10 mM Tris-Cl [pH 7.6], 0.5 mM MgCl2, and 0.6 M NaCl,
plus protease inhibitors as in Dounce buffer) was immediately added to
bring the solution to a final concentration of 150 mM NaCl to prevent disruption of the nuclei. The nuclei were pelleted by centrifugation at
4°C for 5 min at 500 × g. To the supernatant, 0.5 M
EDTA was added to a final concentration of 5 mM, and the membrane
suspensions were centrifuged at 4°C for 45 min at 150,000 × g. Each membrane preparation was solubilized in 200 µl of
resuspension buffer (300 mM NaCl, 50 mM Tris-Cl [pH 7.6], and 0.2%
SDS, plus protease inhibitors).
To measure the membrane-associated NA protein content, we diluted each
membrane preparation in dilution buffer (300 mM NaCl, 50 mM Tris-Cl
[pH 7.5], 0.1% SDS) and spotted 1 µl of the dilutions in duplicate
onto prewetted Immun-Blot polyvinylidene difluoride membranes
(Bio-Rad, Hercules, Calif.). Several dilutions of each membrane were
tested to ensure that attempts to detect the bound protein were within
the linear detection range of the assay. The protein was allowed to
bind for 30 min, after which the membranes were incubated for 1 h
at room temperature in blocking buffer (PBS containing 2% nonfat milk
and 0.05% Tween 20) with gentle agitation. After being blocked and
between subsequent steps, the membranes were washed extensively with
PBS containing 0.1% Tween 20. NA protein was detected by incubating
the blots with a 1:5,000 dilution of the anti-FLAG M2 antibody (Kodak
IB13010) in blocking buffer at room temperature for 1 h. The blots
were then incubated for 1 h at room temperature with a 1:10,000
dilution of anti-mouse horseradish peroxidase-conjugated antibody
(Sigma number A-9044) in blocking buffer. The bound horseradish
peroxidase activity was detected by chemiluminescence with the ECL
Western blotting kit (Amersham, Piscataway, N.J.) according to the
manufacturer's protocol. The optical densities of the spots were
determined with the Kodak KDS1D imaging software. The previously
determined cell-associated NA activities were then normalized to the
relative level of protein expression for each construct. The relative
specific activity for each construct normalized to that of the
pCA/Eng62N2 is reported in Results.
 |
RESULTS |
Growth of reassortant viruses in ducks.
The N2 NA, originally
derived from an avian virus, first appeared in human viruses in 1957. To determine when the NA lost its ability to support the growth of
virus in ducks after its introduction into the human population, we
generated reassortants containing N2 NA genes from human H2N2 viruses
isolated between 1957 and 1968 in the background of all other genes
from avian virus A/duck/Hong Kong/278/78. Although none of the
reassortants differed from the parent avian virus in the ability to
grow in MDCK cell culture or in the allantoic cavity of embryonated
chicken eggs (data not shown), there were marked differences in their replication in the duck intestine (Table
1). Both A/duck/Hong Kong/278/78 and
Dk78/Sing57N2 grew well in this tissue, while reassortant Dk78/AA60N2
grew poorly and Dk78/Eng62N2 and Dk78/Korea68N2 did not grow to
detectable levels. Thus, by 1962 the human virus N2 had lost the
ability to support productive virus replication in orally inoculated
ducks.
N2 NA enzymatic activity in reassortant viruses.
In previous
analyses of the enzymatic activities of avian and human influenza A
virus NAs, we had observed that in preparations of similar virus
concentration, avian viruses generally possessed higher levels of
activity than human viruses (unpublished observations). To measure
differences in the enzymatic properties of the human virus NAs that
might account for their differing abilities to support viral
replication in ducks, we measured the relative specific activities of
the NAs in the reassortants Dk78/Sing57N2, Dk78/AA60N2, and
Dk78/Eng62N2 and compared them with the result for the N2 NA in
Dk78/75N2, which was derived from an avian virus, A/duck/Hong Kong/7/75
(H3N2), in the background of A/duck/Hong Kong/278/78. Dk78/75N2 was
chosen for this analysis because it replicates efficiently in the duck
intestine and its N2 subtype is more closely related in sequence to the
human virus NAs than the N9 NA of A/duck/Hong Kong/278/78. The avian
and A/Singapore/1/57 NAs both possessed high levels of specific
enzymatic activity (Fig. 1), in contrast to the A/Ann Arbor/6/60 and A/England/12/62 NAs, whose activities were
only about 8 and 5%, respectively, of that of the high-activity NAs.
The same trend in activity was observed when this assay was performed
using NeuAc
2,3-lactose as the substrate (data not shown). Thus, an
appreciable reduction in the enzymatic activity of NA during its
adaptation in humans correlates with its reduced ability to support
viral growth in ducks.

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 1.
Relative specific enzymatic activities of avian and
human virus NAs. Enzymatic activity was determined with the MU-NANA
substrate, as described in Materials and Methods. Relative specific
activity was calculated by normalizing NA activity to the level of NA
protein in virions, as determined by nonreducing polyacrylamide gel
electrophoresis of 35S-labeled virions, followed by
autoradiography and densitometric analysis of the NA bands. The results
are shown in relation to the activity of the avian NA of Dk78/75N2, set
at 100%. The error bars indicate standard deviations.
|
|
NA region associated with high specific activity.
To identify
the region of the NA molecule that contained the molecular determinants
for high specific activity, we constructed a series of chimeras in
which regions of the A/England/12/62 NA, the earliest human NA not able
to support viral growth in ducks, were replaced with corresponding
regions of the A/Singapore/1/57 NA (Fig.
2), whose ability to support replication
in ducks parallels that of avian virus NAs. The constructs were
expressed in cell culture, and the cell-associated NA activities and
protein expression levels were used to calculate the relative specific
activity for each construct.

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 2.
Identification of the NA region associated with high
specific activity. (A) The sequence coding for the FLAG epitope tag
(DYKDDDDK) was inserted, in frame, into the NA genes of
A/Singapore/1/57 (Sing/57) and A/England/12/62 (Eng/62), and chimeras 1 to 5 were generated by using shared restriction sites. All genes were
subcloned into the plasmid expression vector pCAGGS/MCS. (B) Two
6-cm2 wells of 293T cells were transfected with 2 µg of
each NA-expressing plasmid/well. 48 h later, the cell-associated
NA activity was determined by using equal numbers of cells transfected
with each NA and 0.1 mM NeuAc 2-3Gal sialyllactose substrate. NA
protein expression levels were determined by isolation of cell
membranes and measurement of NA by chemiluminescent Western blot
analysis with the anti-FLAG antibody. Enzymatic activities were
normalized to protein expression for each NA and are reported relative
to that of A/England/12/62. The error bars indicate standard
deviations.
|
|
The cell-expressed A/Singapore/1/57 NA had about fivefold-higher
specific activity than the A/England/12/62 NA. Substitution in the
A/England/12/62 NA with the A/Singapore/1/57 residues in chimeras 1 and
2 had little effect on enzymatic activity. Chimera 3 had about
3-fold-higher and chimera 4 about 1.5-fold-higher activity than did the
A/England/12/62 NA. When the regions represented by chimeras 3 and 4 were combined in chimera 5, the full activity of the A/Singapore/1/57
NA was generated in the A/England/12/62 NA, indicating that multiple
residues are involved in determining the level of NA specific activity.
Residues from other portions of the molecule, such as those represented
in chimeras 1 and 2, probably do not contribute to this function.
Molecular determinants of high specific activity in NA.
There
are a total of six amino acid differences between the A/Singapore/1/57
and A/England/12/62 NAs in the region represented by chimera 5 (Table
2). To assess the contribution of these
residues to high specific activity, we first examined the effect of
replacing each of the four residues at positions 367, 370, 400, and 431 in A/England/12/62, all of which lie close to the enzymatic active site
(Fig. 3), with the corresponding residue
from A/Singapore/1/57. Mutants containing combinations of two, three,
or all four of these residues were also evaluated. Because residues 331 and 339 were distant from the enzymatic active site, their contribution to specific activity was assessed as a pair in combination with the
other residues under examination. All mutants were evaluated with the
2,3-sialyllactose substrate.
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Amino acid sequence comparison of the N2 NAs of avian and
early human H2N2 viruses in the region represented by chimera 5 (nucleotides 869 to 1467)
|
|

View larger version (105K):
[in this window]
[in a new window]
|
FIG. 3.
Location of amino acid differences between
A/Singapore/1/57 and A/England/12/62 in the region of NA exchanged in
chimera 5. The positions of the amino acid residues (cyan) and the
enzymatic active site, indicated by the position of the bound sialic
acid (purple), are shown on the NA structure of A/Tokyo/3/67 (H3N2)
(23). The fourfold-symmetry axis ( ) that generates the
tetrameric head of NA is perpendicular to the plane of the figure.
|
|
Individual amino acid mutations at residues 370 (mutant B) and 431 (mutant D) led to increased NA activity: 156 and 191% of the value for
A/England/12/62 (Fig. 4). The change in
mutant A at position 367 caused a decrease of 33% in the activity of
A/England/12/62 NA, while the change at residue 400 in mutant C did not
appreciably affect activity. Mutant D, with the highest activity of any
of these altered NAs, was still far less active than the
A/Singapore/1/57 NA. The variable effects of these mutations suggest
that the individual residues do not make a straightforward contribution
to NA specific activity but rather interact in a complex manner such
that residue combinations, perhaps including all residues in chimera 5, cooperate to produce the high activity of the A/Singapore/1/57 NA.

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 4.
Determination of the contributions of individual amino
acid residues to high specific activity. (A) Mutants were generated in
which amino acid residues in the A/England/12/62 (Eng/62) NA were
replaced (X) individually and in groups with the corresponding
A/Singapore/1/57 (Sing/57) residues. (B) The relative specific
activities of the mutants were determined as described in the legend to
Fig. 2. The error bars indicate standard deviations.
|
|
Mutation of residues 400 and 431 as a pair in mutant E, equivalent in
sequence to chimera 4, had no additional effect on activity compared
with the effect of residue 431 (mutant D) alone (Fig. 4). The paired
mutation of residues 367 and 370 in mutant F did not substantially
affect NA activity compared with that of wild-type A/England/12/62.
When the residue 367 mutation was paired with either the residue 400 or
431 mutation (mutants G and H, respectively), it decreased NA activity
compared to results with either residue alone. The combination of
residues 370 and 400 (mutant I) yielded an intermediate NA activity
(between those observed with either residue alone), while the addition
of residue 370 to 431 in mutant J slightly increased the NA activity
relative to that of the 431 mutant (D). Thus, when associated in pairs,
none of these residues can account for the high specific activity of
the A/Singapore/1/57 NA.
The analysis was expanded by generating additional combinations of
three or four amino acid mutations. Changes at positions 367, 370, 400, and 431 in mutant K resulted in an NA with about the same activity as
mutant D (Fig. 4). Although, it was possible to change residue 400 back
to the A/England/12/62 identity (mutant L) without affecting the
activity of the NA, similar reversions involving other residues
produced variable results. For example, mutant M, with the
A/England/12/62 identity at residue 367, had slightly lower activity
than mutant K, whereas reversions at residue 370 in mutant N and 431 in
mutant O to the A/England/12/62 identity dramatically lowered the
respective NA activities to just 65 and 39% of the A/England/12/62
activity. When residues 331 and 339 were introduced in combination with
residues 367 and 370 to generate mutant P, equivalent in sequence to
chimera 3, we observed a 3.8-fold increase in activity compared with
that of the wild-type A/England/12/62 NA. This suggests that the high
specific activity of the A/Singapore/1/57 NA, while partially dependent
on residues 367, 370, and 431, also depends on the identities of
residues 331 and 339, despite their distance from the enzyme's active site.
Finally, a mutant construct containing residues 331 and 339 together
with residues 367, 370, 400, and 431 (mutant Q), equivalent to chimera
5, had the full specific activity of the A/Singapore/1/57 NA (Fig. 4).
Again, the mutation at position 400 (mutant R) was dispensable in
generating a construct with full activity. Thus, the combination of
residues at positions 331, 339, 367, 370, and 431 appears adequate to
restore high levels of specific NA activity to A/England/12/62. By
analogy, the high specific activity of the A/Singapore/1/57 NA can be
viewed as requiring the interplay of several amino acid residues and
cannot be attributed to the identity of the amino acid at any single position.
 |
DISCUSSION |
Understanding the molecular changes that accompany the adaptation
of influenza A virus to a new host can yield important insight into the
requirements for productive viral replication and cross-species transmission. Here, we show that the N2 NA from a human virus, A/Singapore/1/57, can support the replication of an avian reassortant virus with all other genes from A/duck/Hong Kong/278/78 in the duck
intestine following oral inoculation. In similar reassortants, the N2
NA of A/Ann Arbor/6/60 could support virus growth, but at appreciably
reduced efficiency, while the N2 NA of A/England/12/62 and a later
human virus could not. Because all reassortants contained the same
avian genes, with the exception of the NA gene, and the original avian
virus was replication competent in orally inoculated ducks, we reasoned
that clues to the molecular determinants(s) of viral growth resided in
differences among the human NAs. Subsequent analyses revealed high
levels of specific enzymatic activity in avian virus NAs and a human
virus NA isolated in 1957, with sharp reductions in activity for
viruses isolated after 1957. Thus, the loss of ability of most human
viral NAs to support efficient viral replication in the duck intestine
can be associated with reductions in the specific enzymatic activity of
this viral surface glycoprotein.
Hinshaw et al. (5) were the first to note the inability of
human viral NA to support replication in the duck intestine following
oral inoculation. This finding was made with a human-avian reassortant
possessing the N2 NA gene of A/Udorn/307/72 (H3N2), a virus isolated 15 years after the appearance of the N2 subtype of NA in humans, with all
other genes from the avian virus A/mallard/New York/6750/78 (H2N2).
A/Singapore/1/57, in which the HA and NA were both derived from an
avian virus, represents the first appearance of the pandemic human H2N2
viruses in 1957 (20, 21). While the NA of this earliest
human H2N2 virus appears to have retained properties of its avian
ancestor, ongoing changes in later virus isolates, likely due to
adaptation to growth in humans, greatly reduced its ability to support
viral replication in ducks. Thus, by 1962, the human virus N2 NA in the
reassortant Dk78/Eng62N2 was incapable of supporting viral replication
in orally inoculated ducks, while Dk78/AA60N2, with the NA of human
virus A/Ann Arbor/6/60, could replicate in some but not all ducks. In
our analysis, the specific activity of the A/England/12/62 NA was
slightly lower than that of A/Ann Arbor/6/60, but the reduction is too
small to account for the differences in growth among the reassortants. It is possible that the ability of NA to support infection is dependent
on high specific activity and one or more unknown additional properties, retained in the A/Ann Arbor/6/60 NA to some extent, that
disappeared by 1962. We suggest that the NA of A/Ann Arbor/6/60 may
represent an intermediate stage in the adaptation of NA to viral growth
requirements in humans.
For practical reasons, not all possible combinations of the six
residues at positions 331, 339, 367, 370, 400, and 431 were generated
in this study. However, residues 331 and 339 appear indispensable (but
not sufficient by themselves) for high specific NA activity. Although,
the NA of A/Ann Arbor/6/60 has the same amino acid residues at
positions 331, 339, 400, and 431 as does the A/Singapore/1/57 NA, it
possesses low specific activity similar to that of A/England/12/62. The
A/Ann Arbor/6/60 NA has serine at position 367 and valine at 392, similar to the high-activity NA of A/duck/Hong Kong/7/75, but has
leucine at 370 like the A/England/12/62 NA. Because Leu370 represents
the only amino acid difference between the A/Ann Arbor/6/60 NA and
high-activity NAs and it lies in the NA region that determines high
specific activity, residue 370 may be an important determinant of
activity. Residue 367, on the other hand, differs in the NAs of
A/Singapore/1/57 and A/England/12/62 but is the same in both the
high-activity A/duck/Hong Kong/7/75 NA and the low-activity NAs of
A/Ann Arbor/6/60 and A/England/12/62, suggesting that its identity is
not particularly important for determining high specific NA activity.
The identity of residue 431 makes a significant contribution to high
specific activity. Interestingly, this amino acid was also found to be
important for recognition of the N-glycolylneuraminic species of sialic acid (10), an important receptor for
influenza virus replication in the duck intestine (8). As
is evident from the crystallographic structure of the A/Tokyo/3/67 N2
NA (22, 23), the position of residue 431 is too far from
the sialic acid binding pocket of the enzymatic site to directly
interact with the sialic acid species in glycoconjugates, suggesting
that it interacts with a portion of the glycoconjugate farther up the chain (10); however, this prediction is not consistent
with the fact that changes at position 431 can affect enzymatic
activity even with small substrates, such as MU-NANA, which lacks
neighboring sugar moieties. Thus, it could be that proline at position
431 results in conformational changes in the structure of the NA, permitting residue 431 or other residues to directly affect binding and/or activity for sialoglycoconjugates.
The amino acids analyzed in this study showed very high levels of
conservation among avian influenza viruses: all 10 avian viruses with
the N2 subtype shared Ser331, Asp339, Ser367, Ser370, Asn400, and
Pro431 (Table 3). These residues were
also found in the NAs of A/Singapore/1/57 and A/Ann Arbor/6/60, with
the exception of Ser367
Asn in A/Singapore/1/57 and Ser370
Leu in A/Ann Arbor/6/60. The high degree of conservation of the residues at
these six positions in avian viruses indicates the importance of their
contribution to NA function. Most human viruses isolated after 1960 and
all swine viruses display similar substitutions in four of the six
residues of interest. Most notably, in the sequences of 25 human and 13 swine N2 viruses, residue 339 was always asparagine and residue 400 was
always serine (except for one human isolate with arginine). Numerous
replacements were observed at position 431 in human and swine virus
NAs, including Gln, Arg, Lys, Glu, and Gly, but none of the isolates
had the avian proline residue. Residue 331 was also highly conserved
among human viruses isolated after 1962 and in the swine viruses; all
had arginine at position 331 except for a human isolate with lysine and
another with serine. The positions of residues 331 and 339 in the NA
structure would not permit their direct interaction with a substrate,
and they do not participate in the interaction between NA subunits in
the active tetramer form of the enzyme (Fig. 3). Conceivably, these
residues could contribute to high specific activity through long-range
conformational effects. Residues at positions 367 and 370 were more
heterogeneous in identity, displaying overlap between the amino acid
identities in avian viruses and other amino acids found only in the
human and swine viruses. It was also noted that residues 367, 370, and
400, conserved in high-activity NAs, are also important for NA
hemadsorption activity, a conserved property of all NA subtypes in
avian viruses that is lost in human virus NAs (9, 11, 25).
However, the biological significance of NA hemadsorption activity for
viral replication has not been determined (9).
We postulate that the different levels of specific activity of the NAs
from human and avian viruses stem from different viral growth
requirements in the two hosts. Aquatic birds are believed to be the
primordial reservoir for all subtypes of influenza viruses, and the NA
of avian viruses is well adapted to support viral growth in these
hosts. It is likely that high NA specific activity is required for
maintenance of the HA affinity-NA activity balance needed for efficient
growth in the duck intestine. The importance of this balance has been
illustrated in several examples in which NA activity was inhibited by
drugs, reduced by mutagenesis, or removed from virions (4, 6, 13,
14). In these studies, compensatory mutations that reduced HA
affinity for its cellular receptor were observed, and they reduced
viral dependence on NA activity during the budding of progeny virions
from infected cells. Soon after H2N2 viruses were transmitted to
humans, amino acid mutations in the HA increased its affinity for
NeuAc
2-6Gal and reduced its affinity for NeuAc
2-3Gal. Since the
affinity of human virus HAs for NeuAc
2-6Gal is generally less than
that shown by avian virus HAs for NeuAc
2-3Gal (12),
human virus NAs would be expected to require correspondingly less NA
activity for budding of progeny virions. Alternatively, the reduction
in human NA specific activity may simply be related to the removal of
selective pressure on growth in an avian host or even to growth factors
in the human respiratory tract that we do not yet understand.
Our findings help to define the unique requirements for influenza virus
growth among different hosts and the process by which influenza viruses
adapt to new hosts and establish stable lineages. Although H2N2 viruses
had disappeared from humans by about 1968, the adaptation of the
avian-virus-derived N2 NA resulted in the persistence of a
human-adapted NA in H3N2 viruses, which continues to circulate
worldwide. Expanding our understanding of the factors that influence
cross-species transmission and adaptation of influenza viruses may aid
in identifying viruses with the potential to cause pandemic outbreaks
and thus in implementing timely and effective countermeasures.
 |
ACKNOWLEDGMENTS |
We thank Robert G. Webster for providing the antibodies to the N2
and N9 NAs. We are also grateful to Clayton Naeve and the St. Jude
Children's Research Hospital Center for Biotechnology for preparing
oligonucleotides and for computer support. We also thank John Gilbert
for helpful suggestions and for editing the manuscript.
This work was supported by National Institute of Allergy and Infectious
Diseases Public Health Service research grants, Cancer Center Support
(CORE) grant CA-21765, and the American Lebanese Syrian Associated
Charities (ALSAC).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin
Madison, Madison, WI 53706. Phone: (608) 265-4925. Fax: (608) 265-5622. E-mail:
kawaokay{at}svm.vetmed.wisc.edu.
 |
REFERENCES |
| 1.
|
Baum, L. G., and J. C. Paulson.
1991.
The N2 neuraminidase of human influenza virus has acquired a substrate specificity complementary to the hemagglutinin receptor specificity.
Virology
180:10-15[CrossRef][Medline].
|
| 2.
|
Connor, R. J.,
Y. Kawaoka,
R. G. Webster, and J. C. Paulson.
1994.
Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates.
Virology
205:17-23[CrossRef][Medline].
|
| 3.
|
Couceiro, J. N.,
J. C. Paulson, and L. G. Baum.
1993.
Influenza virus strains selectively recognize sialyloligosaccharides on human respiratory epithelium: the role of the host cell in selection of hemagglutinin receptor specificity.
Virus Res.
29:155-165[CrossRef][Medline].
|
| 4.
|
Gubareva, L. V.,
R. Bethell,
G. J. Hart,
K. G. Murti,
C. R. Penn, and R. G. Webster.
1996.
Characterization of mutants of influenza A virus selected with the neuraminidase inhibitor 4-guanidino-Neu5Ac2en.
J. Virol.
70:1818-1827[Abstract].
|
| 5.
|
Hinshaw, V. S.,
R. G. Webster,
C. W. Naeve, and B. R. Murphy.
1983.
Altered tissue tropism of human-avian reassortant influenza viruses.
Virology
128:260-263[CrossRef][Medline].
|
| 6.
|
Hughes, M. T.,
M. Matrosovich,
M. E. Rodgers,
M. McGregor, and Y. Kawaoka.
2000.
Influenza A viruses lacking sialidase activity can undergo multiple cycles of replication in cell culture, eggs, or mice.
J. Virol.
74:5206-5212[Abstract/Free Full Text].
|
| 7.
|
Ito, T.,
J. N. Couceiro,
S. Kelm,
L. G. Baum,
S. Krauss,
M. R. Castrucci,
I. Donatelli,
H. Kida,
J. C. Paulson,
R. G. Webster, and Y. Kawaoka.
1998.
Molecular basis for the generation in pigs of influenza A viruses with pandemic potential.
J. Virol.
72:7367-7373[Abstract/Free Full Text].
|
| 8.
|
Ito, T.,
Y. Suzuki,
T. Suzuki,
A. Takada,
T. Horimoto,
K. Wells,
H. Kida,
K. Otsuki,
M. Kiso,
H. Ishida, and Y. Kawaoka.
2000.
Recognition of N-glycolylneuraminic acid linked to galactose by the 2,3 linkage is associated with intestinal replication of influenza A virus in ducks.
J. Virol.
74:9300-9305[Abstract/Free Full Text].
|
| 9.
|
Kobasa, D.,
M. E. Rodgers,
K. Wells, and Y. Kawaoka.
1997.
Neuraminidase hemadsorption activity, conserved in avian influenza A viruses, does not influence viral replication in ducks.
J. Virol.
71:6706-6713[Abstract].
|
| 10.
|
Kobasa, D.,
S. Kodihalli,
M. Luo,
M. R. Castrucci,
I. Donatelli,
Y. Suzuki,
T. Suzuki, and Y. Kawaoka.
1999.
Amino acid residues contributing to the substrate specificity of the influenza A virus neuraminidase.
J. Virol.
73:6743-6751[Abstract/Free Full Text].
|
| 11.
|
Laver, W. G.,
P. M. Colman,
R. G. Webster,
V. S. Hinshaw, and G. M. Air.
1984.
Influenza virus neuraminidase with hemagglutinin activity.
Virology
137:314-323[CrossRef][Medline].
|
| 12.
|
Matrosovich, M.,
A. Tuzikov,
N. Bovin,
A. Gambaryan,
A. Klimov,
M. R. Castrucci,
I. Donatelli, and Y. Kawaoka.
2000.
Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals.
J. Virol.
74:8502-8512[Abstract/Free Full Text].
|
| 13.
|
McKimm-Breschkin, J. L.,
T. J. Blick,
A. Sahasrabudhe,
T. Tiong,
D. Marshall,
G. J. Hart,
R. C. Bethell, and C. R. Penn.
1996.
Generation and characterization of variants of NWS/G70C influenza virus after in vitro passage in 4-amino-Neu5Ac2en and 4-guanidino-Neu5Ac2en.
Antimicrob. Agents Chemother.
40:40-46[Abstract].
|
| 14.
|
Mitnaul, L. J.,
M. N. Matrosovich,
M. R. Castrucci,
A. B. Tuzikov,
N. V. Bovin,
D. Kobasa, and Y. Kawaoka.
2000.
Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus.
J. Virol.
74:6015-6020[Abstract/Free Full Text].
|
| 15.
|
Niwa, H.,
K. Yamamura, and J. Miyazaki.
1991.
Efficient selection for high-expression transfectants with a novel eukaryotic vector.
Gene
108:193-200[CrossRef][Medline].
|
| 16.
|
Palese, P.,
K. Tobita,
M. Ueda, and R. W. Compans.
1974.
Characterization of temperature-sensitive influenza virus mutants defective in neuraminidase.
Virology
61:397-410[CrossRef][Medline].
|
| 17.
|
Prickett, K. S.,
D. C. Amberg, and T. P. Hopp.
1989.
A calcium-dependent antibody for identification and purification of recombinant proteins.
BioTechniques
7:580-589[Medline].
|
| 18.
|
Rogers, G. N., and J. C. Paulson.
1983.
Receptor determinants of human influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin.
Virology
127:361-373[CrossRef][Medline].
|
| 19.
|
Rogers, G. N., and B. L. D'Souza.
1989.
Receptor binding properties of human and animal H1 influenza virus isolates.
Virology
173:317-322[CrossRef][Medline].
|
| 20.
|
Schäfer, J. R.,
Y. Kawaoka,
W. J. Bean,
J. Suss,
D. Senne, and R. G. Webster.
1993.
Origin of the pandemic 1957 H2 influenza A virus and the persistence of its possible progenitors in the avian reservoir.
Virology
194:781-788[CrossRef][Medline].
|
| 21.
|
Scholtissek, C.,
W. Rohde,
V. Von Hoyningen, and R. Rott.
1978.
On the origin of the human influenza virus subtypes H2N2 and H3N2.
Virology
87:13-20[CrossRef][Medline].
|
| 22.
|
Varghese, J. N., and P. M. Colman.
1991.
Three-dimensional structure of the neuraminidase of influenza virus A/Tokyo/3/67 at 2.2 Å resolution.
J. Mol. Biol.
221:473-486[CrossRef][Medline].
|
| 23.
|
Varghese, J. N.,
J. L. McKimm-Breschkin,
J. B. Caldwell,
A. A. Kortt, and P. M. Colman.
1992.
The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor.
Proteins
14:327-332[CrossRef][Medline].
|
| 24.
|
Webster, R. G.
1970.
Antigenic hybrids of influenza A viruses with surface antigens to order.
Virology
42:633-642[CrossRef][Medline].
|
| 25.
|
Webster, R. G.,
G. M. Air,
D. W. Metzger,
P. M. Colman,
J. N. Varghese,
A. T. Baker, and W. G. Laver.
1987.
Antigenic structure and variation in an influenza virus N9 neuraminidase.
J. Virol.
61:2910-2916[Abstract/Free Full Text].
|
| 26.
|
Webster, R. G.,
W. J. Bean,
O. T. Gorman,
T. M. Chambers, and Y. Kawaoka.
1992.
Evolution and ecology of influenza A viruses.
Microbiol. Rev.
56:152-179[Abstract/Free Full Text].
|
Journal of Virology, December 2001, p. 11773-11780, Vol. 75, No. 23
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.23.11773-11780.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Yen, H.-L., Ilyushina, N. A., Salomon, R., Hoffmann, E., Webster, R. G., Govorkova, E. A.
(2007). Neuraminidase Inhibitor-Resistant Recombinant A/Vietnam/1203/04 (H5N1) Influenza Viruses Retain Their Replication Efficiency and Pathogenicity In Vitro and In Vivo. J. Virol.
81: 12418-12426
[Abstract]
[Full Text]